Baring India Private Equity Fund III has sold a 7.36% stake in India-based active pharmaceutical ingredients manufacturer Shilpa Medicare for INR3.06b (approximately USD41.8m) through an open market transaction. Baring PE India retains a 1.36% stake in the company. Read more